Rationally engineered Losmapimod encapsulating polymeric nanoparticles for treatment of human multiple myeloma cells
- 21 September 2021
- journal article
- research article
- Published by Springer Nature in Applied Nanoscience
- Vol. 11 (9) , 2447-2457
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- New synthesis of phenyl-isothiocyanate C-functionalised cyclams. Bioconjugation and 64 Cu phenotypic PET imaging studies of multiple myeloma with the te2a derivativeOrganic & Biomolecular Chemistry, 2015
- Folate-decorated polymeric Pt( ii ) prodrug micelles for targeted intracellular delivery and cytosolic glutathione-triggered release of platinum anticancer drugsPolymer Chemistry, 2015
- Dual AO/EB Staining to Detect Apoptosis in Osteosarcoma Cells Compared with Flow CytometryMedical Science Monitor Basic Research, 2015
- Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myelomaOrganic & Biomolecular Chemistry, 2013
- The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signalingBiomaterials, 2013
- Inhibitory effect of bortezomib on human multiple myeloma cells when combined with epigallocatechin-gallate (EGCG) analogsMedChemComm, 2011
- Microcalorimetry of Blood Serum Proteome: A Modified Interaction Network in the Multiple Myeloma CaseAnalytical Chemistry, 2011
- Conjugated polyelectrolyte–cisplatin complex nanoparticles for simultaneous in vivo imaging and drug trackingNanoscale, 2011
- Quantitative Proteomic Analysis of Tumor Reversion in Multiple Myeloma CellsJournal of Proteome Research, 2010
- Acridine Orange/Ethidium Bromide (AO/EB) Staining to Detect ApoptosisCold Spring Harbor Protocols, 2006